Financing, Equity Capital Markets

Cogent Biosciences

06/22
|
$172.6 Million
Piper Sandler served as bookrunner for Cogent Biosciences, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma